- Home
- ACHV vs OPRX Comparison
ACHV vs OPRX Comparison
Compare ACHV & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- OPRX
- Stock Information
- Founded
- ACHV N/A
- OPRX 2006
- Country
- ACHV Canada
- OPRX United States
- Employees
- ACHV N/A
- OPRX N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OPRX Business Services
- Sector
- ACHV Health Care
- OPRX Consumer Discretionary
- Exchange
- ACHV Nasdaq
- OPRX Nasdaq
- Market Cap
- ACHV 126.9M
- OPRX 111.2M
- IPO Year
- ACHV N/A
- OPRX N/A
- Fundamental
- Price
- ACHV $2.85
- OPRX $5.41
- Analyst Decision
- ACHV Strong Buy
- OPRX Buy
- Analyst Count
- ACHV 5
- OPRX 8
- Target Price
- ACHV $14.80
- OPRX $9.06
- AVG Volume (30 Days)
- ACHV 283.6K
- OPRX 255.6K
- Earning Date
- ACHV 11-07-2024
- OPRX 11-13-2024
- Dividend Yield
- ACHV N/A
- OPRX N/A
- EPS Growth
- ACHV N/A
- OPRX N/A
- EPS
- ACHV N/A
- OPRX N/A
- Revenue
- ACHV N/A
- OPRX $88,179,506.00
- Revenue This Year
- ACHV N/A
- OPRX $28.59
- Revenue Next Year
- ACHV N/A
- OPRX $10.52
- P/E Ratio
- ACHV N/A
- OPRX N/A
- Revenue Growth
- ACHV N/A
- OPRX 40.40
- 52 Week Low
- ACHV $2.87
- OPRX $3.78
- 52 Week High
- ACHV $5.59
- OPRX $16.65
- Technical
- Relative Strength Index (RSI)
- ACHV 25.46
- OPRX 54.39
- Support Level
- ACHV $3.12
- OPRX $4.72
- Resistance Level
- ACHV $3.86
- OPRX $5.14
- Average True Range (ATR)
- ACHV 0.22
- OPRX 0.45
- MACD
- ACHV -0.04
- OPRX -0.01
- Stochastic Oscillator
- ACHV 0.98
- OPRX 54.35
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.